机译:Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study
START Midwest;
Dept Oncol,Univ Washington;
Ctr Canc,Massachusetts Gen HospYale Canc CtrBundang Hosp,Seoul Natl UnivColl Med,Yonsei UnivSamsung Med Ctr,Sungkyunkwan UnivColl Med,Seoul Natl UnivDana Farber Canc CtrALX OncolInt Drug Dev InstCanc Ctr,Univ Colorado;
THERAPEUTIC TARGET; CD47 BLOCKADE; CELL; PHAGOCYTOSIS; RITUXIMAB;